Alzheimer's agitation drug safety study halted

NCT ID NCT06736509

Summary

This study aimed to check the long-term safety of AXS-05 for treating agitation in people with Alzheimer's disease. It included 139 participants who had completed previous trials of the same medication. The trial was terminated, meaning it ended early before reaching its planned conclusion.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinical Research Site

    Peoria, Arizona, 85381, United States

  • Clinical Research Site

    Walnut Creek, California, 94596, United States

  • Clinical Research Site

    Bonita Springs, Florida, 34134, United States

  • Clinical Research Site

    Brandon, Florida, 33511, United States

  • Clinical Research Site

    Greenacres City, Florida, 33467, United States

  • Clinical Research Site

    Hialeah, Florida, 33012, United States

  • Clinical Research Site

    Miami, Florida, 33126, United States

  • Clinical Research Site

    Miami, Florida, 33145, United States

  • Clinical Research Site

    Miami, Florida, 33155, United States

  • Clinical Research Site

    Miami, Florida, 33165, United States

  • Clinical Research Site

    Miami, Florida, 33173, United States

  • Clinical Research Site

    Miami Gardens, Florida, 33014, United States

  • Clinical Research Site

    Miami Lakes, Florida, 33014, United States

  • Clinical Research Site

    Pembroke Pines, Florida, 33025, United States

  • Clinical Research Site

    Tampa, Florida, 33614, United States

  • Clinical Research Site

    Tampa, Florida, 33634, United States

  • Clinical Research Site

    Braintree, Massachusetts, 02184, United States

  • Clinical Research Site

    Brooklyn, New York, 11229, United States

  • Clinical Research Site

    Charlotte, North Carolina, 28211, United States

  • Clinical Research Site

    Mesquite, Texas, 75149, United States

  • Clinical Research Site

    Arlington, Virginia, 22205, United States

  • Clinical Research Site

    San Juan, 00918, Puerto Rico

Conditions

Explore the condition pages connected to this study.